Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the...
Main Authors: | Daniel P. Cardinali, Gregory M. Brown, Seithikurippu R. Pandi-Perumal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/8/4/44 |
Similar Items
-
A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19
by: Sanjeet Singh, et al.
Published: (2020-05-01) -
COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2
by: Allan Giri, et al.
Published: (2021-06-01) -
The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01) -
Vaccination Criteria based on Factors Influencing COVID-19 Diffusion and Mortality
by: Ilaria Spassiani, et al.
Published: (2020-12-01) -
Repurposing COVID-19 Drive-Through Testing Centers for Mass Vaccination
by: Kim E
Published: (2020-11-01)